Gut Microbiota Promotes Tumor Growth in Mice by Modulating Immune Response.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 29630898.
- Also identified by DOI 10.1053/j.gastro.2018.04.001 and PMC identifier 6035070.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
We studied the effects of gut microbiome depletion by oral antibiotics on tumor growth in subcutaneous and liver metastases models of pancreatic cancer, colon cancer, and melanoma. Gut microbiome depletion significantly reduced tumor burden in all the models tested. However, depletion of gut microbiome did not reduce tumor growth in Rag1-knockout mice, which lack mature T and B cells. Flow cytometry analyses demonstrated that gut microbiome depletion led to significant increase in interferon gamma-producing T cells with corresponding decrease in interleukin 17A and interleukin 10-producing T cells. Our results suggest that gut microbiome modulation could emerge as a novel immunotherapeutic strategy.
Medical subject headings
- Dysbiosis
- Gastrointestinal Microbiome
- Neoplasm Metastasis
- Neoplasms
- T-Lymphocyte Subsets